opioid use
|
disease |
|
Mental or Behavioral Dysfunction
|
39
|
5
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
positive and negative symptoms
|
phenotype |
|
Sign or Symptom
|
18
|
5
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Sleeplessness
|
phenotype |
Nervous System Diseases; Mental Disorders
|
Sign or Symptom
|
174
|
30
|
0.010 |
None |
1.000 |
1 |
2
|
2018 |
2018 |
Psoriasis
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
1308
|
705
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Panic Disorder
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
175
|
101
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Pain, Postoperative
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Sign or Symptom
|
102
|
14
|
0.010 |
None |
1.000 |
1 |
|
2020 |
2020 |
Ischemic stroke
|
disease |
Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
1159
|
704
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Uremic pruritus
|
phenotype |
Pathological Conditions, Signs and Symptoms; Skin and Connective Tissue Diseases
|
Sign or Symptom
|
2
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Opioid withdrawal
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
16
|
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Nicotine withdrawal
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
27
|
1
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Nicotine Dependence
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
170
|
178
|
0.010 |
None |
1.000 |
1 |
|
2020 |
2020 |
Neuroblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
2509
|
386
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Tumor Cell Invasion
|
phenotype |
|
Neoplastic Process
|
6626
|
169
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Mild cognitive disorder
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
430
|
96
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Induced hypothermia (finding)
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Sign or Symptom
|
21
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Lymphoma
|
group |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1548
|
91
|
0.010 |
None |
1.000 |
1 |
|
1995 |
1995 |
Lordosis
|
phenotype |
Musculoskeletal Diseases
|
Disease or Syndrome
|
160
|
15
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Post-Traumatic Stress Disorder
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
418
|
117
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Postoperative cognitive dysfunction
|
phenotype |
|
Mental or Behavioral Dysfunction
|
93
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Central neuroblastoma
|
disease |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
2419
|
231
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Drug usage
|
phenotype |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
170
|
21
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Neoplasm, Residual
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
329
|
23
|
0.010 |
None |
1.000 |
1 |
|
1995 |
1995 |
Malignant Bone Neoplasm
|
disease |
Neoplasms; Musculoskeletal Diseases
|
Neoplastic Process
|
125
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Impaired cognition
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
1630
|
348
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Diagnosis, Psychiatric
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
46
|
1
|
0.010 |
None |
1.000 |
1 |
|
2001 |
2001 |